Comorbidity of Depression and Substance Abuse

Biology of Depression: From Novel Insights to Therapeutic Strategies

Volumn , Issue , 2008, Pages 341-364

  Nunes, Edward V ^a   Raby, Wilfred N ^a  

^a New York State Psychiatric Institute ^*  (United States)

Author keywords

Addictions; Drugs; Etiology; Mood disorders; Substance abuse

Indexed keywords

EID: 33746900942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619672.ch13     Document Type: Chapter

References (95)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th Edit. American Psychiatric Association, Washington, DC, 1994.
2. Anda, R. F., Whitfield, C. L., Felitti, V j., Chapman, D., Edwards, V. J., Dube, S. R., Williamson, D. F., Adverse childhood experiences, alcoholic parents, and later risk of alcoholism and depression. Psychiatr. Serv. 2002, 53, 1001-1009.
3. Armstrong, T D., Costello, E. J., Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity: a literature review. J. Consult. Clin. Psychol. 2002, 70, 1224-1239.
4. Baer, J. S., Sampson, P. D., Barr, H. M., Connor, P. D., Streissguth, A. p., A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking. Arch. Gen. Psychiatry 2003, 60, 377-385.
5. Berggren, U., Eriksson, M., Fahlke, C., Balldin, J., Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. Drug Alcohol Depend. 2002, 65, 159-165.
6. Bjork, J. M., Grant, S. J., Hommer, D. W., Cross-sectional volumetric analysis of brain atrophy in alcohol dependence: effects of drinking history and comorbid substance use disorder. Am. J. Psychiatry 2003, 160, 2038-2045.
7. Breslau, N., Kilbey, M. M., Andreski P: Nicotine dependence and major depression: new evidence from a prospective investigation. Arch. Gen. Psychiatry 1993, 50, 31-35.
8. Brook, J. S., Brook, D. W., Gordon, A. S., et al., The psychosocial etiology of adolescent drug use: a family interactional approach. Genet. Soc. Gen. Psychol. Monogr. 1990, 116, 111-267.
9. Brook, D. W., Brook, J. S., Zhang, C., Cohen, p., Whiteman, M., Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch. Gen. Psychiatry 2002, 59, 1039-1044.
10. Brown, R. A., Lejuez, C. W., Kahler, C. W., Strong, D. R., Distress tolerance and duration of past smoking cessation attempts. J. Abnorm. Psychol. 2002, 111, 180-185.
11. Brown, S. A., Schuckit, M. A., Changes in depression among abstinent alcoholics. J. Stud. Alcohol 1988, 49, 412-417.
12. Brown, S. A., Inaba, R. K., Gillin, J. C., Schuckit, M. A., Stewart, M. A., Irwin, M. R., Alcoholism and affective disorder: clinical course of depressive symptoms. Am. J. Psychiatry 1995, 152, 45-52.
13. Buka, S. L., Shenassa, E. D., Niaura, R., Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am. J. Psychiatry 2003, 160, 1978-1984.
14. Carroll, K. M., Nich, C., Rounsaville, B. J., Differential symptom reduction in depressed cocaine abusers treated with psychotherapy or pharmacotherapy. J. Nerv. Ment. Dis. 1995, 183, 251-259.
15. Charney, D. S., Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 2004, 161, 195-216.
16. Chick, J., Aschauer, H., Hornik, K., Investigators Group. Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, doubleblind, placebo-controlled multicentre study with analysis by typology. Drug Alcohol Depend. 2004, 74, 61-70.
17. Clark, D. B., De Bellis, M. D., Lynch, K. G., Cornelius, J. R., Martin, C. S., Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes. Drug Alcohol Depend. 2003, 69, 51-60.
18. Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., Angold, A., Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry 2003, 60, 837-844.
19. Covey, L. S., Glassman, A. H., Stetner, F., Major depression following smoking cessation. Am. J. Psychiatry 1997, 154, 263-265.
20. DeLeon, G., Skodol, A., Rosenthal, M. S., Phoenix House: changes in psycho-pathological signs of resident drug addicts. Arch. Gen. Psychiatry 1973, 28, 131-135.
21. Drake, R. E., McHugo, G. j., Clark, R. E., Teague, G. B., Xie, H., Miles, K., Ackerson, T. H., Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am. J. Orthopsychiatry 1998, 68, 201-215.
22. Evans, S. M., Haney, M., Foltin, R. W., The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl.) 2002, 159, 397-406.
23. Fergusson, D. M., Horwood, L. J., Swain-Campbell N: Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97, 1123-1135.
24. Fu, Q., Heath, A. C., Bucholz, K. K., Nelson, E., Goldberg, J., Lyons, M. J., True, W. R., Jacob, T., Tsuang, M. T., Eisen, S. A., Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch. Gen. Psychiatry 2002, 59, 1125-1132.
25. Gelernter, J., Kranzler, H., Coccaro, E. F., Siever, L. J., New, A. S., Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am. J. Psychiatry 1998, 155, 1332-1338.
26. Gerra, G., Garofano, L., Santoro, G., Bosari, S., Pellegrini, C., Zaimovic, A., Moi, G., Bussandri, M., Moi, A., Brambilla, F., Donnini, C., Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am. J. Med. Genet. 2004, 126B, 37-42.
27. Gilman, S. E., Abraham, H. D., A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend. 2001, 63, 277-286.
28. Glassman, A. H., Cigarette smoking: implications for psychiatric illness. Am.J. Psychiatry 1993, 150, 546-553.
29. Glassman, A. H., Helzer, J. E., Covey, L. S., Cottler, L. B., Stetner, F., Tipp, J. E., Johnson, J., Smoking, smoking cessation, and major depression. JAMA 1990, 264, 1546-1549.
30. Goldstein, R. Z., Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159, 1642-1652.
31. Grant, B. F., Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey. J. Subst. Abuse 1995, 7, 481-497.
32. Grant, B. F., Harford TC: Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995, 39, 197-206.
33. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., Kaplan, K., Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2004, 61, 807-816.
34. Hall, S. M., Reus, V. I., Munoz, R. F., et al., Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch. Gen. Psychiatry 1998, 55, 683-690.
35. Hanna, E. Z., Yi, H. Y., Dufour, M. C., Whitmore, C. C., The relationship of early-onset regular smoking to alcohol use, depression, illicit drug use, and other risky behaviors during early adolescence: results from the youth supplement to the third national health and nutrition examination survey. J. Subst. Abuse 2001, 13, 265-282.
36. Hasin, D., Liu, X., Nunes, E., et al., Effects of major depression on remission and relapse of substance dependence. Arch. Gen. Psychiatry 2002, 59, 375-380.
37. Hasin, D., Nunes, E., Meydan, J., Comorbidity of alcohol, drug and psychiatric disorders: epidemiology. In: Kranzler, H. R., Tinsley, J. A. (Eds.), Dual Diagnosis and Treatment: Substance Abuse and Comorbid Disorders. New York: Dekker; 2004.
38. Havassy, B. E., Alvidrez, J., Owen, K. K., Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am. J. Psychiatry 2004, 161, 139-145.
39. Heinz, A., Mann, K., Weinberger, D. R., Goldman, D., Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin. Exp. Res. 2001, 25, 487-495.
40. Hellerstein, D. J., Rosenthal, R. N., Miner, C. R., Integrating services for schizophrenia and substance abuse. Psychiatr. Q 2001, 72, 291-306.
41. Higgins, S. T., Budney, A. J., Bickel, W. K., Hughes, J. R., Foerg, F., Badger, G., Achieving cocaine abstinence with a behavioral approach. Am. J. Psychiatry 1993, 150, 763-769.
42. Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B., Niaurra, R., History of depression and smoking cessation outcome: a meta-analysis. J. Consult. Clin. Psychol. 2003, 71, 657-663.
43. Hrometz, S. L., Brown, A. W., Nichols, D. W., Sprague, J. E., 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B. Neurosci. Lett. 2004, 367, 56-59.
44. Jacob, C. p., Strobel, A., Hohenberger, K., Ringel, T., Gutknecht, L., Reif, A., Brocke, B., Lesch, K. p., Association between allelic variation of serotonin transporter function and neuroticism in anxious cluster C personality disorders. Am. J. Psychiatry 2004, 161, 569-572.
45. Johnson, B. A., Serotonergic agents and alcoholism treatment: rebirth of the subtype concept-an hypothesis. Alcohol Clin. Exp. Res. 2000, 24, 1597-1601.
46. Kasen, S., Cohen, p., Skodol, A. E., Johnson, J. G., Smailes, E., Brook, J. S., Childhood depression and adult personality disorder: alternative pathways of continuity. Arch. Gen. Psychiatry 2001, 58, 231-236.
47. Kellam, S. G., Brown, C. H., Rubin, B. R., et al., Paths leading to teenage psychiatric symptoms and substance use: developmental epidemiological studies in Woodlawn. In: Guze, S. B., Earls, F. J., Barrett, J. E. (Eds.), Childhood Psychopathology and Development. New York: Raven Press; 1983, pp 17-51.
48. Kellam, S. G., Werthamer-Larsson, L., Dolan, L. J., et al., Developmental epidemiologically based preventive trials; baseline modeling of early target behaviors and depressive symptoms. Am. J. Commun Psychol. 1991, 19, 563-584.
49. Kelsoe, J. R., Promoter prognostication: the serotonin transporter gene and antidepressant response. Mol. Psychiatry 1998, 3, 475-476.
50. Kendler, K. S., Neale, M. C., MacLean, C. J., et al., Smoking and major depression: a causal analysis. Arch. Gen. Psychiatry 1993a; 50, 3643.
51. Kendler, K. S., Heath, A. C., Neale, M. C., et al., Alcoholism and major depression in women: a twin study of the causes of comorbidity. Arch. Gen. Psychiatry 1993b; 50, 690-698.
52. Kendler, K. S., Prescott, C. A., Myers, J. K., et al., The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 2003, 60, 929-937.
53. Kenford, S. L., Smith, S. S., Wetter, D. W., Jorenby, D. E., Fiore, M. C., Baker, T. B., Predicting relapse back to smoking: contrasting affective and physical models of dependence. J. Consult. Clin. Psychol. 2002, 70, 216-227.
54. Kessler RC: Epidemiology of psychiatric comorbidity. In: Tsuang, M. T., Tohen, M., Zahner, G. E. P. (Eds.), Textbook in Psychiatric Epidemiology. New York: Wiley; 1995, pp 179-197.
55. Khantzian, E. J., The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am.J. Psychiatry 1985, 142, 1259-1264.
56. Klein, D. N., Schwartz, J. E., Rose, S., Leader, J. B., Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am.J. Psychiatry 2000, 157, 931-939.
57. Koob, G. F., Stress, corticotropin-releasing factor, and drug addiction. Ann. NY Acad. Sci. 1999, 897, 27-45.
58. Kranzler, H. R., Burleson, J. A., Brown, J., Babor, T. F., Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin. Exp. Res. 1996, 20, 1534-1541.
59. Kuperman, S., Schlosser, S. S., Kramer, J. R., Bucholz, K., Hesselbrock, V., Reich, T., Reich, W., Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. Am. J. Psychiatry 2001, 158, 2022-2026.
60. Kushner, M. G., Sher, K. J., Erickson, D. J., Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders. Am. J. Psychiatry 1999, 156, 723-732.
61. Lampe, I. K., Hulshoff Pol, H. E., Janssen, J., Schnack, H. G., Kahn, R. S., Heeren, T. J., Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder. Am. J. Psychiatry 2003, 160, 2052-2054.
62. Liappas, J., Paparrigopoulos, T., Tzavellas, E., Christodoulou, G., Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend. 2002, 68, 215-220.
63. Malanga, C. J., Kosofsky, B. E., Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure. Brain Res. Dev. Brain Res. 2003, 147, 47-57.
64. Markou, A., Kosten, T. R., Koob, G. F., Neurobiologic similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998, 18, 135-174.
65. Niaura, R., Bock, B., Lloyd, E. E., Brown, R., Lipsitt, L. P., Buka, S., Maternal transmission of nicotine dependence: psychiatric, neurocognitive and prenatal factors. Am. J. Addict. 2001, 10, 16-29.
66. Nunes, E. V., Levin, F. R., Treatment of depression in patients with alcohol or drug dependence: a meta-analysis. JAMA 2004, 291, 1887-1896.
67. Nurnberger, J. I. Jr., Foroud, T., Flury, L., Su, J., Meyer, E. T., Hu, K., Crowe, R., Edenberg, H., Goate, A., Bierut, L., Reich, T., Schuckit, M., Reich, W., Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am.J. Psychiatry 2001, 158, 718-724.
68. Patton, G. C., Coffey, C., Carlin, J. B., et al., Cannabis use and mental health in young people: cohort study. BMJ 2002, 325, 1195-1198.
69. Pettinati, H. M., Volpicelli, J. R., Kranzler, H. R., Luck, G., Rukstalis, M. R., Cnaan, A., Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin. Exp. Res. 2000, 24, 1041-1049.
70. Pope, H. G. Jr., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., Yurgelun-Todd, D., Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003, 69, 303-310.
71. Rachbeisel, J., Scott, J., Dixon, L., Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr. Serv. 1999, 50, 1427-1434.
72. Randall, D. M., Cox, W. M., Experimental mood inductions in persons at high and low risk for alcohol problems. Am. J. Drug Alcohol Abuse 2001, 27, 183-187.
73. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., Goodwin, F. K., Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264, 2511-2518.
74. Rosenblum, A., Fallon, B., Magura, S., Handelsman, L., Foote, J., Bernstein, D., The autonomy of mood disorders among cocaine-using methadone patients. Am. J. Drug Alcohol Abuse 1999, 25, 67-80.
75. Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., Kupfer, D. J., Rosenbaum, J. F., Alpert, J., Stewart, J. W., McGrath, P. J., Biggs, M. M., Shores-Wilson, K., Lebowitz, B. D., Ritz, L., Niederehe G; STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D), rationale and design. Control Clin. Trials 2004, 25, 119-142.
76. Salloum, I. M., Thase, M. E., Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000, 2, 269-280.
77. Sapolsky, R. M., Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57, 925-935.
78. Satel, S. L., Price, L. H., Palumbo, J. M., McDougle, C. J., Krystal, J. H., Gawin, F., Charney, D. S., Heninger, G. R., Kleber, H. D., Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am. J. Psychiatry 1991, 148, 1712-1716.
79. Schuckit, M. A., The clinical implications of primary diagnostic groups among alcoholics. Arch. Gen. Psychiatry 1985, 42, 1043-1049.
80. Schuckit, M. A., Genetic and clinical implications of alcoholics and affective disorder. Am. J. Psychiatry 1986, 143, 140-147.
81. Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Mori, N., Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am. J. Psychiatry 2003, 160, 1699-1701.
82. Sofuoglu, M., Brown, S., Babb, D. A., Hatsukami, D. K., Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend. 2001, 63, 131-137.
83. Sofuoglu, M., Dudish-Poulsen, S., Brown, S. B., Hatsukami, D. K., Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug Alcohol Depend. 2003, 69, 273-282.
84. Spring, B., Pingitore, R., McChargue, D. E., Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am. J. Psychiatry 2003, 160, 316-322.
85. Strain, E. C., Stitzer, M. L., Bigelow, G. E., Early treatment time course of depressive symptoms in opiate addicts. J. Nerv. Ment. Dis. 1991, 179, 215-221.
86. Tarter, R. E., Kirisci, L., Mezzich, A., Cornelius, J. R., Pajer, K., Vanyukov, M., Gardner, W., Blackson, T., Clark, D., Neurobehavíoral disinhibition in childhood predicts early age at onset of substance use disorder. Am. J. Psychiatry 2003, 160, 1078-1085.
87. Thapar, A., Fowler, T. A., Rice, F., Scourfield, J., van den Bree, M., Thomas, H., Harold, G., Hay, D., Maternal smoking in pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am. J. Psychiatry 2003, 160, 1985-1989.
88. Tidey, J. W., Mehl-Madrona, L., Higgins, S. T., Badger, G. J., Psychiatric symptom severity in cocaine-dependent outpatients: demographics, drug use characteristics and treatment outcome. Drug Alcohol Depend. 1998, 50, 9-17.
89. Tong, J., Ross, B. M., Schmunk, G. A., Peretti, F. J., Kalasinsky, K. S., Furukawa, Y., Ang, L. C., Aiken, S. S., Wickham, D. J., Kish, S. J., Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am. J. Psychiatry 2003, 160, 896-903.
90. Tremblay, L. K., Naranjo, C. A., Cardenas, L., Herrmann, N., Busto, U. E., Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch. Gen. Psychiatry 2002, 59, 409-416.
91. Uslaner, J., Kalechstein, A., Richter, T., Ling, W., Newton, T., Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am. J. Psychiatry 1999, 156, 1444-1446.
92. Wang, G. J., Volkow, N. D., Chang, L., Miller, E., Sedler, M., Hitzemann, R., Zhu, W., Logan, J., Ma, Y., Fowler, J. S., Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am. J. Psychiatry 2004, 161, 242-248.
93. Weddington, W. W., Brown, B. S., Haertzen, C. A., Cone, E. J., Dax, E. M., Herning, R. I., Michaelson, B. S., Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: a controlled, residential study. Arch. Gen. Psychiatry 1990, 47, 861-868.
94. Willner, p., Field, M., Pitts, K., Reeve, G., Mood, cue and gender influences on motivation, craving and liking for alcohol in recreational drinkers. Behav. Pharmacol. 1998, 9, 631-642.
95. Zvolensky, M. J., Feldner, M. T., Eifert, G. H., Brown, R. A., Affective style among smokers: understanding anxiety sensitivity, emotional reactivity, and distress tolerance using biological challenge. Addict. Behav. 2001, 26, 901-915.